New strategic partnership strengthens Lonza's position as leading supplier to the life science industry
Strategic partnership concluded with Novartis for the joint development and manufacture of its biological pipeline
Novartis and Lonza have entered into a long term strategic partnership for the joint development and manufacture of the Novartis biological pipeline. Lonza will contribute its biotech leadership knowledge in process development and the manufacturing of complex processes to the collaboration. In combination with the strong Novartis research and development pipeline, the agreement generates significant benefits for both parties.
The collaboration will involve Lonza in the development, scale-up and manufacturing of Novartis biological pipeline. Lonza will provide development services from its R&D center in Slough, UK, using Lonza's GS Gene Expression System(TM), and large scale manufacturing capacity from its operations in the US, Spain and Singapore.
This strategic partnership represents an extension of Lonza's Contract Manufacturing Business model, expanding from a product by product development and manufacturing arrangement towards the joint development of a pipeline of products with its customers.
Novartis has a pipeline of pharmaceutical products in numerous therapeutic areas. The collaboration will fulfill their need for additional resources in technical development. It will also provide Novartis with extra manufacturing capacity, to be utilized in a flexible way.
"We are delighted to enter into this collaboration. For Lonza, it represents a change in approach from a typical CMO deal. It focuses on a real collaborative approach to development and manufacturing asset planning to ensure our customers can bring their pipeline of products to the market in an efficient and timely manner", said Dr. Stephan Kutzer, Head of Lonza Biopharmaceuticals. "We believe this is the beginning of a long partnership that will bring significant benefits to both parties."
Organizations
Other news from the department business & finance

Get the analytics and lab tech industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.